Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Puts Down $50m For Mesoblast COVID-19 Cell Therapy

Reversal Of Fortunes For Remestemcel-L

Nov 20 2020

• By Kevin Grogan

Rescue — Novartis comes to Mesoblast's rescue • Source: Shutterstock

Related Content

Keeping Track: Disappointment For Mesoblast And Aquestive; Opdivo/Yervoy Add Mesothelioma Claim; Pediatric Approvals

Oct 03 2020

Mesoblast’s Cell Therapy For Pediatric GVHD Gets US Panel Green Light Despite FDA's "Substantial Concerns"

Aug 14 2020

Mesoblast, Athersys Take Lead In Race To Develop Stem Cell Therapies For COVID-19

Jul 21 2020

Related Companies

Mesoblast Limited

Novartis AG

Incyte Corporation

Additional Topics

Coronavirus COVID-19 Deals Commercial Companies Respiratory BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window